Keros Therapeutics Inc (KROS)

Total Costs & Expenses

$116.48M

TTM · Period ending: · USD

KROS logo

KROS Total Costs & Expenses

Latest reported$116.48M
KROS TTM Total Costs & Expenses ($20.56M → $116.48M)
High-resolution chart · PNG

KROS total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Keros Therapeutics Inc Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
116,482,000
143,530,000
176,492,000
203,133,000
232,532,000
225,023,000
214,383,000
204,685,000
188,928,000
179,789,000
170,092,000
155,454,000
140,142,000
129,533,000
114,790,000
107,697,000
99,918,000
84,831,000
76,474,000
64,898,000
56,649,000
51,922,000
46,657,000
38,594,000
31,472,000
25,709,000
20,563,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.